TickerFacts.

Compare

KORU Medical Systems, Inc. vs SS Innovations International, Inc. vs Interpace Biosciences, Inc. vs SANUWAVE Health, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearKORU Medical Systems, Inc.
KRMD		SS Innovations International, Inc.
SSII		Interpace Biosciences, Inc.
IDXG		SANUWAVE Health, Inc.
SNWV
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$41.13M$42.48M$38.73M$44.05M
Revenue growth (YoY)+22.2%+105.7%-17.5%+35.0%
Gross margin62.3%46.0%62.3%77.1% (computed)
Operating margin-7.2%-19.3%10.5%11.2%
Net margin-6.4%-28.5%63.5%26.8%
Net income-$2.64M-$12.13M$24.57M$11.81M
EPS (Diluted)-$0.06-$0.06$0.89$0.41
Operating cash flow$462.4K-$18.54M$5.83M$3.88M
Free cash flow-$470.1K-$22.20M$5.47M$1.93M
Cash & equivalents$8.87M$3.21M$2.50M$11.96M
Total assets$28.20M$74.23M$33.84M$37.34M
Total liabilities$11.15M$36.01M$11.47M$35.72M
Shareholders' equity$17.05M$38.22M$22.36M$1.62M
Return on year-end equity-15.5%-31.7%109.9%729.6%
Shares outstanding46.37M194.17M4.43M8.59M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearKORU Medical Systems, Inc.SS Innovations International, Inc.Interpace Biosciences, Inc.SANUWAVE Health, Inc.
Latest$41.13M
Ended 2025-12-31		$42.48M
Ended 2025-12-31		$38.73M
Ended 2025-12-31		$44.05M
Ended 2025-12-31
1 year earlier$33.65M
Ended 2024-12-31		$20.65M
Ended 2024-12-31		$46.93M
Ended 2024-12-31		$32.63M
Ended 2024-12-31
2 years earlier$28.52M
Ended 2023-12-31		$5.88M
Ended 2023-12-31		$40.04M
Ended 2023-12-31		$20.40M
Ended 2023-12-31
3 years earlier$27.90M
Ended 2022-12-31		$1.44M
Ended 2022-12-31		$31.84M
Ended 2022-12-31		$16.74M
Ended 2022-12-31
4 years earlier$23.49M
Ended 2021-12-31		n/a$33.12M
Ended 2021-12-31		$13.01M
Ended 2021-12-31